Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tdap Vaccine in People Aged 10 Years and Older
NCT07894055Phase 2Recruiting
- Sponsor
- Changchun BCHT Biotechnology Co.
- Start
- Aug 2026
- Primary completion
- Sep 2026
- Countries
- 1
01
Overview
A Phase 2 trial of tdap vaccine in pertussis, diphtheria, Tetanus, sponsored by Changchun BCHT Biotechnology Co.. Started Aug 2026; status: recruiting.
02
Drugs
tdap vaccine
03
Conditions
pertussisdiphtheriaTetanus
Beyond the preview
Go deeper on NCT07894055.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07894055.